检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘敬梅 LIU Jingmei(Second People's Hospital of Fuxin City,Liaoning Province(Maternity Hospital of Fuxin City,Liaoning Province),Fuxin,Liaoning,123000,China)
机构地区:[1]辽宁省阜新市第二人民医院(阜新市妇产医院)神经内科二病房,辽宁阜新123000
出 处:《当代医学》2021年第8期57-59,共3页Contemporary Medicine
摘 要:目的探讨吡拉西坦氯化钠注射液联合尼莫地平序贯疗法治疗脑出血的疗效。方法选取2018年5月至2019年7月本院接收的50例脑出血患者作为研究对象,按照随机数表法分为对照组与治疗组,每组25例。对照组采用吡拉西坦氯化钠注射液治疗,治疗组在对照组基础上联合尼莫地平序贯疗法治疗。比较两组临床疗效及治疗前、治疗1个月后免疫功能变化情况。结果治疗组治疗总有效率高于对照组,且治疗1个月后,治疗组CD3+、CD4+/CD8+均高于对照组,差异具有统计学意义(P<0.05)。结论吡拉西坦氯化钠注射液联合尼莫地平序贯疗法治疗脑出血疗效显著,可有效促进患者神经功能恢复,改善免疫功能,值得临床推广应用。Objective To investigate the therapeutic effect of piracetam sodium chloride injection combined with nimodipine sequential therapy on cerebral hemorrhage.Methods 50 patients with cerebral hemorrhage admitted to our hospital from May 2018 to July 2019 were selected as reseach subjects.They were divided into control group and treatment group,with 25 cases in each group.The control group was treated with piracetam sodium chloride injection,the treatment group was treated with nimodipine sequential therapy on the basis of the control group.The clinical effect between the two groups and the changes of immune function before and after 1 month of treatment were compared.Results The clinical effect of treatment group was higher than that of control group,and after 1 month of treatment,CD3+,CD4+/CD8+in the treatment group were higher than those in the control group,the difference was statistically significant(P<0.05).Conclusion The effect of piracetam sodium chloride injection combined with nimodipine sequential therapy for cerebral hemorrhage is remarkable,can effectively promote the recovery of nerve function in patients,improving immunity,it is worth learning from.
关 键 词:脑出血 吡拉西坦氯化钠注射液 尼莫地平序贯疗法 免疫功能
分 类 号:R743.34[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.49